NORML

OCTOBER 21, 2019

Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.

DEA 104

DEA Cultivation Clinical Trials Policy 104

Cannabis Law Report

FEBRUARY 28, 2022

Patents on psychedelics raise unique concerns associated with their unusual qualities, history, and regulation. 640, 640 (2011). patent law facilitates the issuance of psychedelic patents that would likely be found invalid if properly scrutinized. Because they were criminalized for decades, the U.S. See Rachel Quibell et al.,

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

MAY 1, 2019

PUBLISHER: CANNABIS LAW REPORT. In February of this year, the California Bureau of Cannabis Control (“CBCC”) sent a letter to Weedmaps.com alleging that the website was “engaging in activity that violates state cannabis laws.” If nature abhors a vacuum, Congress abhors any space not yet filled with federal laws. John McKay.

Legalization 45

Legalization Business Law Cannabis 45

Cannabis Law Report

MAY 24, 2022

Facts and Procedural History: The Controlled Substances Act was passed in 1970 and created a single legal framework for regulating substances that are thought to have a high risk of abuse and addiction. To consider the full impact of this Supreme Court decision it is necessary to delve into the history of the Controlled Substance Act.

DEA 52

DEA History Medicine Marijuana 52

Cannabis Law Report

APRIL 8, 2022

To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. Lyle Craker, Ph.D., million in the form of a bequest.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

SEPTEMBER 23, 2019

During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. The AAFP also recognizes that several states have passed laws approving limited recreational use and/or possession of marijuana. The World Health Organization (WHO) reports approximately 2.5% Background.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

The Cannigma

FEBRUARY 16, 2022

Listen & Subscribe: In light of Black History Month, we feel it is important and relevant to talk about how minorities in the United States and around the world have been disproportionately affected by drug policy and the war on drugs. EG: So, it is February, which means it’s Black History Month in the US right, Codi?

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73